Bill
HF 105
Overview: HF 105 is a bill that relates to the definition of medical cannabidiol.Purpose and Intent: The bill aims to update the definition of medical cannabidiol, which is a non-p
Overview: HF 105 is a bill that relates to the definition of medical cannabidiol.
Purpose and Intent: The bill aims to update the definition of medical cannabidiol, which is a non-psychoactive compound derived from the cannabis plant. The goal is to ensure the definition accurately reflects the current scientific understanding and regulatory landscape surrounding medical cannabidiol.
Key Provisions:
- Revises the definition of medical cannabidiol to align with federal and state regulations
- Clarifies the allowed concentration levels of tetrahydrocannabinol (THC) in medical cannabidiol products
- Maintains the existing framework for the medical use of cannabidiol in the state
Affected Parties and Impacts: The bill primarily affects patients who use medical cannabidiol, as well as the healthcare providers and businesses involved in the production, distribution, and sale of these products. The updated definition may impact the availability and accessibility of medical cannabidiol for patients.
Procedural and Timeline Considerations: The bill has been approved by a committee and renumbered as HF 950, indicating it is progressing through the legislative process.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
